AU2015263901B2 - Compositions and methods for stabilizing luminogenic substrates - Google Patents
Compositions and methods for stabilizing luminogenic substrates Download PDFInfo
- Publication number
- AU2015263901B2 AU2015263901B2 AU2015263901A AU2015263901A AU2015263901B2 AU 2015263901 B2 AU2015263901 B2 AU 2015263901B2 AU 2015263901 A AU2015263901 A AU 2015263901A AU 2015263901 A AU2015263901 A AU 2015263901A AU 2015263901 B2 AU2015263901 B2 AU 2015263901B2
- Authority
- AU
- Australia
- Prior art keywords
- att
- composition
- days
- alkyl
- furimazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent materials, e.g. electroluminescent or chemiluminescent
- C09K11/06—Luminescent materials, e.g. electroluminescent or chemiluminescent containing organic luminescent materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Electroluminescent Light Sources (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462002363P | 2014-05-23 | 2014-05-23 | |
| US62/002,363 | 2014-05-23 | ||
| PCT/US2015/032439 WO2015179864A1 (en) | 2014-05-23 | 2015-05-26 | Compositions and methods for stabilizing luminogenic substrates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2015263901A1 AU2015263901A1 (en) | 2016-11-24 |
| AU2015263901B2 true AU2015263901B2 (en) | 2021-03-11 |
Family
ID=53434457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015263901A Active AU2015263901B2 (en) | 2014-05-23 | 2015-05-26 | Compositions and methods for stabilizing luminogenic substrates |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9676997B2 (enExample) |
| EP (1) | EP3146066B1 (enExample) |
| JP (1) | JP6641297B2 (enExample) |
| KR (1) | KR102456212B1 (enExample) |
| CN (1) | CN106661028B (enExample) |
| AU (1) | AU2015263901B2 (enExample) |
| BR (1) | BR112016027504B1 (enExample) |
| CA (1) | CA2949447C (enExample) |
| SG (1) | SG11201609382WA (enExample) |
| WO (1) | WO2015179864A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3661932B1 (en) | 2017-08-04 | 2021-10-06 | Promega Corporation | Compositions and methods for stabilizing benzothiazole luciferin analogs |
| IL318819A (en) | 2018-10-03 | 2025-04-01 | Promega Corp | Compounds and methods for stabilizing cholinetyrazine and its derivatives |
| CN111116594B (zh) * | 2019-12-03 | 2021-05-28 | 山东大学 | 一种C-6位改造NanoLuc类型类似物及其制备方法与应用 |
| CN121399275A (zh) * | 2024-05-21 | 2026-01-23 | 深圳琅技生命科技有限公司 | 用于稳定腔肠素及其类似物的组合物及方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2000622A1 (de) * | 1970-01-08 | 1971-07-22 | Agfa Gevaert Ag | Verfahren zur Stabilisierung von Silberbildern |
| US20080020384A1 (en) * | 2006-07-24 | 2008-01-24 | National Institute Of Advanced Industrial Science And Technology | Stabilizing composition and stabilizing method of coelenterazine solution for high-throughput measurement of luciferase activity |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4639904B2 (ja) * | 2005-03-30 | 2011-02-23 | チッソ株式会社 | 蛍光活性を有するルシフェラーゼの活性増強方法 |
| JP4761150B2 (ja) * | 2006-07-24 | 2011-08-31 | 独立行政法人産業技術総合研究所 | ハイスループット発光活性測定のためのセレンテラジン(ウミシイタケルシフェリン)溶液の安定化組成物および安定化法 |
| EP2626703B1 (en) * | 2008-03-27 | 2017-05-03 | Promega Corporation | Protein labeling with cyanobenzothiazole conjugates |
| CN103443121B (zh) | 2010-11-02 | 2016-04-20 | 普罗梅加公司 | 新型腔肠素底物及其使用方法 |
-
2015
- 2015-05-26 EP EP15730321.5A patent/EP3146066B1/en active Active
- 2015-05-26 CN CN201580026864.3A patent/CN106661028B/zh active Active
- 2015-05-26 KR KR1020167033229A patent/KR102456212B1/ko active Active
- 2015-05-26 CA CA2949447A patent/CA2949447C/en active Active
- 2015-05-26 SG SG11201609382WA patent/SG11201609382WA/en unknown
- 2015-05-26 JP JP2016569444A patent/JP6641297B2/ja active Active
- 2015-05-26 US US14/721,727 patent/US9676997B2/en active Active
- 2015-05-26 WO PCT/US2015/032439 patent/WO2015179864A1/en not_active Ceased
- 2015-05-26 BR BR112016027504-7A patent/BR112016027504B1/pt active IP Right Grant
- 2015-05-26 AU AU2015263901A patent/AU2015263901B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2000622A1 (de) * | 1970-01-08 | 1971-07-22 | Agfa Gevaert Ag | Verfahren zur Stabilisierung von Silberbildern |
| US20080020384A1 (en) * | 2006-07-24 | 2008-01-24 | National Institute Of Advanced Industrial Science And Technology | Stabilizing composition and stabilizing method of coelenterazine solution for high-throughput measurement of luciferase activity |
Non-Patent Citations (2)
| Title |
|---|
| F.CH. KARIMOV ET AL, "Stabilization of poly(vinyl chloride) by 3-mercapto-1,2,4-triazin-5-one derivatives", POLYMER DEGRADATION AND STABILITY, (1996), vol. 52, no. 2, pages 197 - 199 * |
| PUSTOSHNAYA L S ET AL, "Antioxidant effect of triazinone derivatives in thermal oxidation of polyisoprene", POLYMER DEGRADATION AND STABILITY, (2000), vol. 70, no. 1, pages 39 - 41 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3146066B1 (en) | 2018-03-14 |
| WO2015179864A1 (en) | 2015-11-26 |
| BR112016027504A2 (enExample) | 2017-08-15 |
| SG11201609382WA (en) | 2016-12-29 |
| AU2015263901A1 (en) | 2016-11-24 |
| JP2017519977A (ja) | 2017-07-20 |
| KR102456212B1 (ko) | 2022-10-20 |
| US20150337198A1 (en) | 2015-11-26 |
| BR112016027504B1 (pt) | 2023-04-18 |
| CN106661028B (zh) | 2021-08-06 |
| US9676997B2 (en) | 2017-06-13 |
| CA2949447A1 (en) | 2015-11-26 |
| EP3146066A1 (en) | 2017-03-29 |
| JP6641297B2 (ja) | 2020-02-05 |
| CA2949447C (en) | 2022-10-04 |
| CN106661028A (zh) | 2017-05-10 |
| KR20170012271A (ko) | 2017-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2949447C (en) | Compositions and methods for stabilizing luminogenic substrates | |
| Patel et al. | New 4-thiazolidinones of nicotinic acid with 2-amino-6-methylbenzothiazole and their biological activity | |
| EP3728276B1 (en) | Novel tunable photoactivatable silicon rhodamine fluorophores | |
| Fang et al. | Design, synthesis, and evaluation of new 2-oxoquinoline arylaminothiazole derivatives as potential anticancer agents | |
| El-Sherif et al. | One pot synthesis of novel thiazolo [3, 2-b][1, 2, 4] triazoles: A useful synthetic application of the acidified acetic acid method | |
| EP3661932B1 (en) | Compositions and methods for stabilizing benzothiazole luciferin analogs | |
| Pinson et al. | Synthesis and pharmacological evaluation of 4-iminothiazolidinones for inhibition of PI3 kinase | |
| Venkateswararao et al. | Exploration and Optimization of an Efficient One‐pot Sequential Synthesis of Di/tri‐substituted Thiazoles from α‐Bromoketones, Thioacids Salt, and Ammonium Acetate | |
| JPH11171883A (ja) | 立体障害アミンを基材とする新規の光安定剤 | |
| Kim et al. | Synthesis, structure, and UV–VIS absorption spectra of azo dyes derived from (dialkylamino) thiazole dimers | |
| US20040214999A1 (en) | Novel compounds for chemiluminescense procedures | |
| FI73436C (fi) | Foerfarande foer framstaellning av som laekemedel anvaendbara rifamyciner. | |
| Connor et al. | Synthesis and antiallergy activity of 10-oxo-10H-pyrido [1, 2-a] thieno [3, 2-d] pyrimidines and 10-oxo-10H-pyrido [1, 2-a] thieno [3, 4-d] pyrimidines | |
| Worzakowska et al. | Pyrolysis and oxidative decomposition mechanism of trifluoromethylated fused triazinones | |
| Kindahl et al. | Efficient one-step synthesis of 4-amino substituted phthalimides and evaluation of their potential as fluorescent probes | |
| JP2017519977A5 (enExample) | ||
| Sellstedt et al. | Synthesis and Characterization of a Multi Ring‐Fused 2‐Pyridone‐Based Fluorescent Scaffold | |
| Cabrera-Rivera et al. | Photophysical properties of 2, 3-dihydroquinazolin-4 (1H)-one derivatives | |
| Andrade et al. | Self-association of free base porphyrins with aminoacid substituents in AOT reverse micelles | |
| Shindy et al. | Effects of chemical structure, solvent and solution pH on the visible spectra of some new methine cyanine dyes | |
| Stadlbauer et al. | Study of the thermal behavior of azidohetarenes with differential scanning calorimetry | |
| JP2020529442A5 (enExample) | ||
| Nadaraj et al. | Synthesis and characterization of condensed pyrazole derivative | |
| Abed et al. | Synthesis, Identification, and Antioxidant Activity Evaluation of New Diazine 2-Sulfanylbenzoxadiazole Derivatives | |
| Sahu et al. | Novel 3-benzyl-2, 6-diarylpiperidin-4-one derivatives: syntheses, characterization, and antimicrobial profile |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |